Pruritus clinical trials at UC Davis

2 research studies open to eligible people

Showing trials for

  • Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)

    “Volunteering for the GLISTEN trial could bring much-needed medical progress in PBC itch!”

    open to eligible people ages 18-80

    This is a 2-part study in PBC participants with cholestatic pruritus and will evaluate the efficacy, safety and impact on health-related quality of life of linerixibat compared with placebo.

    Sacramento, California and other locations

  • Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)

    “Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”

    open to eligible people ages 12 years and up

    The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Sclerosing Cholangitis (PSC), and to assess the possible impact on the disease progression of PSC.

    Sacramento, California and other locations

Our lead scientists for Pruritus research studies include .

Last updated: